Information contained in this news release is current as of the date of the press announcement, but may be subject to change without prior notice.
Epistra and Hitachi leverage AI to achieve one of the world's largest yields and up to a 73% reduction in lab experiment iterations in the production of “(S)-Reticuline,” a pharmaceutical intermediate from Fermelanta
In order to read a PDF file, you need to have Adobe Acrobat Reader installed in your computer.
